Trials / Sponsors / Tioga Pharmaceuticals
Tioga Pharmaceuticals
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS). Vasomotor Symptoms | Phase 2 | 2025-08-13 |
| Completed | Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis Pruritus, Atopic Dermatitis | Phase 2 | 2015-07-01 |
| Completed | A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers Healthy | Phase 1 | 2011-06-01 |
| Completed | Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Diarrhea Predominant Irritable Bowel Syndrome | Phase 3 | 2010-05-01 |
| Terminated | Asimadoline for the Treatment of Post-Operative Ileus Post-Operative Ileus | Phase 2 | 2007-01-01 |
| Completed | Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome Irritable Bowel Syndrome | Phase 2 | 2006-08-01 |